On the one hand, NFIB acts as a tumor‐promoting gene in small‐cell lung cancer (SCLC) 12, 13, 14, 15, melanoma 16, breast cancer 17, 18, and colon cancer 19. This evidence concerns the gene NFIB and breast carcinoma.